Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIFU
2101
AIFU Inc. Class A Ordinary Share
AIFU
$82.6M
| $2.77M | ﹤0.01% |
5,205
+155
| +3% | +$82.5K |
|
|
NBRV
2102
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $2.76M | ﹤0.01% |
5,517
+320
| +6% | +$160K |
|
2103
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $2.76M | ﹤0.01% |
+93,000
| New | +$2.76M |
|
2104
Tanger
SKT
$3.86B
| $2.75M | ﹤0.01% |
177,300
-1,296,516
| -88% | -$20.1M |
|
2105
StoneX
SNEX
$5.04B
| $2.74M | ﹤0.01% |
149,904
+48,375
| +48% | +$883K |
|
|
ABTX
2106
DELISTED
Allegiance Bancshares, Inc.
ABTX
| $2.74M | ﹤0.01% |
85,240
+6,900
| +9% | +$221K |
|
2107
Quad
QUAD
$333M
| $2.73M | ﹤0.01% |
260,000
-58,400
| -18% | -$614K |
|
|
BLCM
2108
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $2.73M | ﹤0.01% |
260,106
+103,610
| +66% | +$1.09M |
|
2109
Omega Flex
OFLX
$340M
| $2.73M | ﹤0.01% |
26,700
+3,000
| +13% | +$307K |
|
2110
H.B. Fuller
FUL
$3.33B
| $2.73M | ﹤0.01% |
58,600
-139,700
| -70% | -$6.5M |
|
2111
Enphase Energy
ENPH
$4.92B
| $2.73M | ﹤0.01% |
122,700
-1,147,928
| -90% | -$25.5M |
|
|
ARGO
2112
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.72M | ﹤0.01% |
38,665
-57,100
| -60% | -$4.01M |
|
2113
Eventbrite
EB
$262M
| $2.71M | ﹤0.01% |
+153,000
| New | +$2.71M |
|
|
APTS
2114
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $2.71M | ﹤0.01% |
187,300
+87,600
| +88% | +$1.27M |
|
2115
Compugen
CGEN
$125M
| $2.7M | ﹤0.01% |
638,600
+80,800
| +14% | +$342K |
|
|
QTRH
2116
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $2.7M | ﹤0.01% |
2,075,056
+335,049
| +19% | +$436K |
|
2117
Guaranty Bancshares
GNTY
$557M
| $2.7M | ﹤0.01% |
96,940
+12,870
| +15% | +$358K |
|
2118
Global Water Resources
GWRS
$271M
| $2.69M | ﹤0.01% |
227,125
+2,462
| +1% | +$29.1K |
|
2119
Embotelladora Andina Series A
AKO.A
$3.12B
| $2.69M | ﹤0.01% |
155,200
+400
| +0.3% | +$6.92K |
|
|
EPZM
2120
DELISTED
Epizyme, Inc
EPZM
| $2.68M | ﹤0.01% |
260,088
-171,700
| -40% | -$1.77M |
|
2121
Spero Therapeutics
SPRO
$107M
| $2.68M | ﹤0.01% |
252,803
+37,900
| +18% | +$402K |
|
2122
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $2.68M | ﹤0.01% |
21,000
+3,700
| +21% | +$472K |
|
|
OIIM
2123
DELISTED
02Micro International Limited
OIIM
| $2.67M | ﹤0.01% |
1,994,295
+9,735
| +0.5% | +$13K |
|
2124
Ultralife
ULBI
$114M
| $2.67M | ﹤0.01% |
308,272
-29,728
| -9% | -$257K |
|
|
GMRE
2125
Global Medical REIT
GMRE
$512M
| $2.67M | ﹤0.01% |
234,145
+49,300
| +27% | +$562K |
|